Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

被引：0
|
作者：
Xia Xu
Fei Deng
Mengmeng Lv
Binhui Ren
Wenwen Guo
Xiaoxiang Chen
机构：
[1] Department of Chemotherapy,
[2] Jiangsu Cancer Hospital,undefined
[3] Department of Gynecologic Oncology,undefined
[4] Jiangsu Cancer Hospital,undefined
[5] Department of Thoracic Oncology,undefined
[6] Jiangsu Cancer Hospital,undefined
[7] The Second Affiliated Hospital of Nanjing Medical University,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
High grade serous ovarian cancer; CA-125; Ascites; Primary debulking surgery; Interval debulking surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
    Xu, Xia
    Deng, Fei
    Lv, Mengmeng
    Ren, Binhui
    Guo, Wenwen
    Chen, Xiaoxiang
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [2] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer
    Xia Xu
    Fei Deng
    Mengmeng Lv
    Xiaoxiang Chen
    Archives of Gynecology and Obstetrics, 2017, 295 : 451 - 458
  • [3] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer
    Xu, Xia
    Deng, Fei
    Lv, Mengmeng
    Chen, Xiaoxiang
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (02) : 451 - 458
  • [4] Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients
    Zhang, Jie
    Liu, Ning
    Zhang, Aihong
    Bao, Xiangxiang
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (09) : 1808 - 1816
  • [5] New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
    Huo, Chuying
    Wu, Bin
    Ye, Dongdong
    Xu, Miaochun
    Ma, Shaolin
    Cheng, Aoshuang
    Liu, Yunyun
    Huang, Chunxian
    Zhang, Yuhao
    Lin, Zhongqiu
    Li, Bowen
    Lu, Huaiwu
    BMC CANCER, 2024, 24 (01)
  • [6] Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
    Luo, Yanlin
    Lee, Maria
    Kim, Hee Seung
    Chung, Hyun Hoon
    Song, Yong Sang
    MEDICINE, 2016, 95 (36)
  • [7] Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
    Lee, Yong Jae
    Woo, Ha Young
    Kim, Yoo-Na
    Park, Junsik
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Park, Eunhyang
    Joung, Je-Gun
    Lee, Jung-Yun
    CANCERS, 2022, 14 (09)
  • [8] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Marchocki, Zibi
    Tone, Alicia
    Virtanen, Carl
    de Borja, Richard
    Clarke, Blaise
    Brown, Theodore
    May, Taymaa
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [9] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Zibi Marchocki
    Alicia Tone
    Carl Virtanen
    Richard de Borja
    Blaise Clarke
    Theodore Brown
    Taymaa May
    Journal of Ovarian Research, 15
  • [10] Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
    Vallius, Tuulia
    Hynninen, Johanna
    Auranen, Annika
    Carpen, Olli
    Matomaki, Jaakko
    Oksa, Sinikka
    Virtanen, Johanna
    Grenman, Seija
    TUMOR BIOLOGY, 2014, 35 (12) : 12389 - 12395
12345